Literature DB >> 35793454

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.

Kai Rejeski1,2,3, Andreas Burchert4, Gloria Iacoboni5,6, Pierre Sesques7, Lars Fransecky8, Veit Bücklein1,2, Corinna Trenker4, Rafael Hernani9, Ralph Naumann10, Jonas Schäfer4, Viktoria Blumenberg1,2,3, Christian Schmidt1, Kristina Sohlbach4, Michael von Bergwelt-Baildon1,3, Emmanuel Bachy7, Pere Barba5,6, Marion Subklewe1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35793454     DOI: 10.1182/bloodadvances.2022007776

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  1 in total

1.  Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia.

Authors:  Lu Han; Ran Zhao; Jingyi Yang; Yingling Zu; Yanyan Liu; Jian Zhou; Linlin Li; Zhenghua Huang; Jishuai Zhang; Quanli Gao; Yongping Song; Keshu Zhou
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.